A cough syrup can be found in most households. It’s usually part of some basic meds that you keep along with paracetamol and some antacids. So this may sound strange at first: can cough syrups really be addictive?

For most cough syrups, and most people who take cough syrups for a genuine cough, the answer is no. But there are some specific cough medicines, ones that contain codeine, an opioid, that can lead to addiction. And in India, that has been happening for decades. There are news articles about seizures of cough syrup bottles. 

Codeine dependence is not a moral failing. It is a recognized medical condition. In this blog, we explore how something used for everyday remedy can cause dependence, who is at risk, and understand the real health dangers associated with it. 

Which cough syrups can be addictive?

Not all cough syrups are addictive. The plain expectorants, the antihistamine-only formulas, the honey-and-ginger syrups that coat a sore throat: these carry little to no risk of addiction. If that is what is in your cabinet, there is nothing to worry about. The problem lies with a much smaller group of ingredients, and knowing which ones matters far more than avoiding cough syrup altogether.

The main problem is codeine. Codeine is an opioid, from the same broad family as morphine, and syrups built around it are the ones with genuine potential for dependence. In India, these were sold for years under widely recognised brand names like Corex, Phensedyl, Eskuf and others, before regulators moved against them. 

Most codeine combinations have since been restricted or pulled from legitimate production. Yet the syrups persist through diverted stock and a large illicit market, which is a big part of why the problem has not disappeared.

Dextromethorphan (DXM), a non-opioid cough suppressant, is not addictive in the ordinary sense but becomes dissociative and mind-altering at high doses. A systematic review of over-the-counter medicine misuse found it the single most-reported misused cough ingredient worldwide. Then there are promethazine-and-codeine combinations, which form the base of what is known globally as “purple drank” or “lean,” a mix that has crept into youth and music culture references in India too.

Why do cough syrups contain codeine in the first place?

If codeine can cause dependence, it is fair to ask why it ended up in cough medicine at all. A cough is a reflex, controlled by a “cough centre” in the brainstem. Codeine acts directly on that centre, dampening the signal that tells the body to keep coughing. For a dry, exhausting, sleep-wrecking cough, the kind that lingers for weeks after an infection, this can bring real relief when gentler remedies have failed.

Codeine also eases the general aches and discomfort that often come with being unwell. For a long time, that made it a genuinely useful ingredient, not a reckless one. The catch lies in what codeine is. It is an opioid, and the body does not use it as-is. Codeine is what pharmacologists call a prodrug: the liver converts it into morphine using an enzyme called CYP2D6. That is why codeine can relieve a cough and, at higher doses or with repeated use, produce a wave of calm and mild euphoria.

This conversion also explains why codeine affects people so differently. The CYP2D6 enzyme varies from person to person. Some people are “ultra-rapid metabolisers” who turn codeine into morphine unusually fast, which means even a normal dose can hit harder and carry a higher risk of toxicity, including dangerously slowed breathing.

Others process it slowly and feel little effect at all. This is not something a person can predict from the outside, which is part of why codeine is meant to be used carefully and under guidance.

The drivers of abuse 

The problem sits at the meeting point of easy access, low cost, a distinct kind of high, a vast illicit supply, and the simple fact that it often starts by accident. For decades, these syrups were sold across pharmacy counters far more freely than the rules intended, a prescription requirement that was widely unenforced.

Doctors in cities like Bengaluru describe access and affordability as the heart of the problem: the syrup is cheap, it is familiar, and it is easy to get. That low cost matters more than it might seem. A codeine syrup is far cheaper than most street drugs, which puts it within reach of young people and lower-income users who could never afford heroin.

Then there is the image. Because it is “just medicine,” codeine syrup carries far less stigma than a substance like charas or brown sugar. Nobody feels like they are doing drugs when they open a cough bottle. Researchers noted this pattern in India as far back as the 1990s; low price, easy availability, and a “clean,” pure preparation were named as key reasons for its rising popularity, and very little about those drivers has changed since.

Behind all of this is a large and stubborn illicit supply chain. Syrup manufactured legally gets diverted into the black market. The scale is striking: seizures now routinely run into lakhs of bottles, from a 15.7-lakh-vial haul in Ghaziabad to multi-crore consignments intercepted on trains heading through the Northeast. These numbers are worth reading not as crime headlines but as a measure of how much demand exists, and how much medicine is quietly leaking out of legitimate channels.

Finally, and most importantly, much of it begins innocently. A person is prescribed a syrup for a real, miserable cough. The relief feels good. They take a little more, a little longer, and tolerance builds so quietly that dependence arrives before anyone has named it.

Who is most affected? 

The picture of who becomes dependent on codeine syrup in India is remarkably consistent across the research. But one general limitation to keep in mind is that these studies are usually only done on people who reached treatment. 

The clearest pattern is sex. In the Indian clinical record, codeine syrup dependence is overwhelmingly male. A North Indian study of treatment-seeking patients found every single one was male, and an earlier study across Assam and Nagaland found the same. That said, this near-total male picture should be read carefully. Women may be far less likely to seek treatment or be identified, because of stigma, caregiving roles, or the ease of using a “medicine” privately at home, so their absence from the data does not necessarily mean their absence from use.

The second pattern is youth. This is largely a problem of the young. In the North Indian cohort, the average age of starting was around 23. In the Northeast, it began even earlier; first use averaged between 15 and 17 years. This mirrors the global evidence, where systematic reviews consistently identify adolescents and young adults as the highest-risk group for misusing cough medicines.

Peer influence is enormous. In the North Indian study, close to nine in ten users had started through friends, most simply out of curiosity, not despair or intent. But the ordinary social pull of trying what those around them were trying. Dependence then followed fast, often within months.

What are the health risks of codeine cough syrup?

• Dependence and withdrawal – This is the most common harm. The body gets used to codeine, and stopping becomes hard. Withdrawal from codeine looks like withdrawal from other opioids. There can be body aches, restlessness, trouble sleeping, stomach cramps, and strong cravings. In one study, more than nine in ten patients went through this kind of withdrawal. Doctors also point out that relapse rates are high and quitting on your own is tough. This is exactly why so many people try to stop and cannot.
• Overdose and acute danger – Codeine is an opioid, and like all opioids, too much of it slows the body down. High doses can cause heavy sedation, and in serious cases, breathing can slow to a dangerous level. The classic warning signs are pinpoint pupils, extreme drowsiness, and slow breathing. The risk goes up for people who process codeine quickly into morphine, and it goes up sharply when syrup is mixed with alcohol or sleeping pills. This combination can be fatal.
• Longer-term and other harms – Cough syrups contain a lot of sugar, so heavy daily use can damage teeth. Many people who become dependent also struggle with other conditions. In the same study, about a quarter had a mental health condition alongside their syrup use; most were using other substances too, and a significant number reported behaviours that raised their risk of HIV.

The takeaway here is not that cough syrup is dangerous for everyone. It is that codeine syrup, used the wrong way or for too long, carries real and serious risks. And most of these risks are hard to spot until dependence has already taken hold.

How to recognise cough syrup addiction?

How do you know when using has crossed the line into dependence? It usually happens gradually, so it can be hard to spot, especially when the thing being used is “just medicine.” But there are some clear signs worth watching for.

• You may be looking at dependence if a person needs more syrup than before to get the same effect. 
• If they start using it when there is no cough at all. 
• If they feel unwell, restless, or on edge when they try to stop. 
• If they begin hiding how much they use, or how often. 

Any one of these on its own may not mean much. Together, they usually point to a real problem.

If some of this sounds familiar, whether in yourself or someone you care about, the most important thing to know is this: codeine dependence is treatable. The ICD-11, the medical system doctors use to classify health conditions, recognises opioid dependence as exactly that, a medical condition, not a weakness or a bad habit. And like other medical conditions, it responds to proper care.

That care matters. Because withdrawal from codeine can be difficult, stopping suddenly and alone often does not work, and can be unpleasant enough to push a person straight back to using. 

Supervised withdrawal, where a professional helps manage the physical symptoms, along with counselling to work through the reasons behind the use, gives a far better chance of lasting recovery. Help is available, and reaching out is a sign of strength, not failure.

Support is available

If you or someone you know is struggling with cough syrup use, support is closer than you think. Here are a few centers that treat opioid and substance dependence along with other addictions: 

• Zorbacare, Mumbai – A residential de-addiction centre in Mumbai offering medically supervised detox, individual and group therapy, family counselling, and aftercare. It treats alcohol, drug, and opioid dependence, including prescription and cough syrup misuse.
• Abhasa, Thondamuthur (Coimbatore) – A residential rehabilitation and wellness centre set near the Velliangiri Hills in Tamil Nadu. It offers medically supervised detox, therapy, and holistic programmes for addiction and mental health, and treats substance dependence alongside conditions like depression and anxiety.
• Aroha, Faridabad – An inpatient rehabilitation centre on the outskirts of Delhi. It provides detox, evidence-based therapy, and medication-assisted treatment for opioid, alcohol, and other substance addictions, as well as support for co-occurring mental health conditions.

Check out de-addiction centers across India on rehabs.in here.